Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Electrical Current01:10

Electrical Current

7.2K
Electrical current is defined as the rate at which charge flows. When there is a large current present, such as that used to run a refrigerator, a large amount of charge moves through the wire in a small amount of time. If the current is small, such as that used to operate a handheld calculator, a small amount of charge moves through the circuit over a long period of time. The SI unit for current is the ampere (A), named for the French physicist André-Marie Ampère (1775–1836).
7.2K
Group Therapy01:26

Group Therapy

450
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
450
Current Density01:21

Current Density

5.2K
The total amount of current flowing through one unit value of a cross-sectional area is referred to as current density. If the current flow is uniform, the amount of current flowing through a conductor is the same at all points along the conductor, even if the conductor area varies. The current density consists of the local magnitude and direction of the charge flow, which varies from point to point. Current density is measured in amperes per meter square, and direction is defined as the net...
5.2K
Eddy Currents01:25

Eddy Currents

2.7K
Since eddy currents occur only in conductors, magnets can separate metals from other materials. For example, in a recycling center, trash is dumped in batches down a ramp, beneath which lies a powerful magnet. Conductors in the trash are slowed by eddy currents, while nonmetals in the trash move on, separating from the metals. This works for all metals, not just ferromagnetic ones.
Other major applications of eddy currents appear in metal detectors and the braking systems of trains and roller...
2.7K
Displacement Current01:19

Displacement Current

3.8K
Ampère's law, in its usual form, does not work in places where the current changes with time and is not steady. Thus, Maxwell suggested including an additional contribution, called the displacement current, Id, to the real conduction current I.
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of automated bone scan indexes in patients with prostate cancer: aBSI and BONENAVI.

Annals of nuclear medicine·2026
Same author

Preparation and Evaluation of Radiolabeled Porphyrin-Functionalized Lipid Nanodroplets for Cancer Theranostics.

Molecules (Basel, Switzerland)·2026
Same author

High-dose ¹³¹I-metaiodobenzylguanidine therapy in relapsed high-risk neuroblastoma: a descriptive analysis of clinical outcomes and associated factors.

European journal of nuclear medicine and molecular imaging·2026
Same author

Multicenter development and validation of a probability-based model to diagnose Lewy body disease using ¹²³I-meta-iodobenzylguanidine.

European journal of nuclear medicine and molecular imaging·2026
Same author

Clinical applications and future directions of Iodine-131-Metaiodobenzylguanidine therapy in neuroblastoma: from salvage treatment to frontline integration.

Annals of nuclear medicine·2026
Same author

Characteristics of lower limb skeletal muscle activity during walking in patients with knee osteoarthritis and knee extensor weakness: Comprehensive assessment using positron emission tomography.

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology·2025

Related Experiment Video

Updated: Feb 6, 2026

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

Published on: September 23, 2018

9.5K

Current Consensus on I-131 MIBG Therapy.

Daiki Kayano1,2, Seigo Kinuya1

  • 11Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641 Japan.

Nuclear Medicine and Molecular Imaging
|August 14, 2018
PubMed
Summary

Metaiodobenzylguanidine (MIBG) therapy, using Iodine-131 (I-131) or Astatine-211 (At-211), shows promise for neuroendocrine tumors. Further research is needed for optimal therapeutic protocols.

Keywords:
Carcinoid tumorsIodine-131 metaiodobenzylguanidineMedullary thyroid cancerNeuroblastomaParagangliomaPheochromocytoma

More Related Videos

Transcranial Direct Current Stimulation tDCS in Mice
11:54

Transcranial Direct Current Stimulation tDCS in Mice

Published on: September 23, 2018

15.2K
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
03:50

Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment

Published on: August 2, 2024

2.0K

Related Experiment Videos

Last Updated: Feb 6, 2026

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

Published on: September 23, 2018

9.5K
Transcranial Direct Current Stimulation tDCS in Mice
11:54

Transcranial Direct Current Stimulation tDCS in Mice

Published on: September 23, 2018

15.2K
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
03:50

Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment

Published on: August 2, 2024

2.0K

Area of Science:

  • Nuclear medicine
  • Oncology
  • Radiopharmaceutical therapy

Background:

  • Metaiodobenzylguanidine (MIBG) targets neuroendocrine cells, similar to norepinephrine.
  • Iodine-131 (I-131)-labeled MIBG (I-131 MIBG) has been used for over 25 years in treating neuroendocrine tumors.
  • Indications include neuroblastoma, pheochromocytoma, paraganglioma, carcinoid tumors, and medullary thyroid cancer.

Purpose of the Study:

  • To review the established and emerging applications of I-131 MIBG therapy.
  • To explore the potential of novel radiolabeled agents like Astatine-211-labeled meta-astatobenzylguanidine (At-211 MABG).
  • To highlight the need for further research into optimized therapeutic protocols.

Main Methods:

  • Review of existing literature on I-131 MIBG therapy for neuroendocrine tumors.
  • Discussion of the principles and applications of MIBG targeting.
  • Exploration of advancements in radiopharmaceutical development, including no-carrier-aided (NCA) I-131 MIBG and At-211 MABG.

Main Results:

  • I-131 MIBG is effective for advanced neuroblastoma, pheochromocytoma, and paraganglioma.
  • For carcinoid tumors and medullary thyroid cancer, I-131 MIBG is an alternative after novel therapies.
  • No-carrier-aided (NCA) I-131 MIBG and At-211 MABG show significant therapeutic potential.

Conclusions:

  • I-131 MIBG remains a valuable treatment for specific neuroendocrine tumors.
  • NCA I-131 MIBG and At-211 MABG represent promising advancements in radiopharmaceutical therapy.
  • Further clinical and preclinical studies are essential to refine therapeutic strategies and protocols.